BioInno Bioscience Co., Ltd. (BioInno) is an international biopharmaceutical CDMO with serum-free cell culture media development and manufacturing. We are committed to providing global biopharmaceutical companies with one-stop CDMO services including cell line development, process development, clinical material manufacturing, IND application filing and GMP manufacturing of BLA and marketed products, with a service platform for customized development and manufacturing of cell culture media as well as quality auditing and consultation.
Our founding team has gathered world-class experts with extensive experience to allow the company to have world-class CDMO operation capability since the beginning of our establishment. Xiaojian (David) Zhao, PhD, is an internationally renowned scientist and biopharmaceutical expert in the field of cell culture and cell culture media. He has developed dozens of mainstream high-end serum-free media and feeds that are currently still marketed globally and has accumulated decades of experience in biopharmaceutical R&D and manufacturing...
Mission: Enable Patients to Use Advanced Biopharmaceuticals at an Affordable Price.
Vision: Customer Focus / Quality First / Honesty & Integrity / Collaboration & Partnership /
Responsibility & Career / Innovation & Development
BioInno Rapid Product Commercialization Fellowship
Enables startups and early-stage projects to reach the market sooner at a lower cost